XARELTO®
(rivaroxaban)
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
XARELTO® (rivaroxaban)
Medical Information
XARELTO - Reversal Agents in Human Studies - Other - Activated Charcoal
Last updated : 05/16/2024
In a case report documented by Mehta et al (2012)1:
- A 21-month-old female ingested two 10 mg tablets of XARELTO.
- Activated charcoal (1 g/kg) was given approximately 2 hours after ingestion.
- The patient’s INR peaked to 3.5 approximately 12 hours after ingestion, and subsequently fell to 1.7 at 20 hours after ingestion of the tablets.
INR, international normalized ratio.
Reference
Show Hide
1.Mehta PD, Christian MR, Kanter MZ. Coagulopathy after accidental pediatric rivaroxaban ingestion. Clin Toxicol. 2012;50(7):Abstract 3
